Questions emerge over level of protection vaccines offer against COVID variants

Findings from a new study in Israel suggest Pfizer's vaccine was less effective at offering protection against the coronavirus variant first detected in South Africa. Carl Zimmer, the New York Times "Matter" columnist and award-winning science writer, joins CBSN's "Red & Blue" to explain why people should get vaccinated anyway.